Atsushi Mizokami

53PUBLICATIONS
78CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical biochemistry - proteins and peptides (incl. medical proteomics)Molecular targetsMedical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

|Oct 07, 2026
Treatment-Effect Heterogeneity and a Simple Framework for Estimating Survival Benefit Associated With Local Therapy in Nonmetastatic Advanced Prostate Cancer: A Multicenter KAMU-ON Cohort Study.

|Sep 24, 2026
Prognostic Value of a Novel Risk Score Combining Psoas Muscle Density and ALBI Grade in Localized Renal Cell Carcinoma.

|Aug 31, 2026
Comparative Prognostic Impact of Two-Dimensional and Three-Dimensional Computed Tomography-Based Sarcopenia Indices in Metastatic Castration-Sensitive Prostate Cancer.

|Aug 25, 2026
Stage-Specific Temporal Trends in Treatment Patterns and Overall Survival in Prostate Cancer: A Multicentre Real-World Cohort Study From KAMU-ON.

|Aug 15, 2026
Survival Benefit of ARSI Therapy in Japanese mCSPC: A Systematic Review and Meta-Analysis.

|Aug 14, 2026
Sequential Enzalutamide-Docetaxel Versus Abiraterone-Docetaxel Therapy in Castration-Resistant Prostate Cancer: A Subanalysis of the ENABLE Study.

Pageof 9

Frequent Collaborators

36 joint publications

Kouji Izumi

26 joint publications

Hiroaki Iwamoto

20 joint publications

Kazuyoshi Shigehara

20 joint publications

Tomoyuki Makino